- Home
- CWST vs JAZZ Comparison
CWST vs JAZZ Comparison
Compare CWST & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWST
- JAZZ
- Stock Information
- Founded
- CWST 1975
- JAZZ 2003
- Country
- CWST United States
- JAZZ Ireland
- Employees
- CWST N/A
- JAZZ N/A
- Industry
- CWST Environmental Services
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- CWST Utilities
- JAZZ Health Care
- Exchange
- CWST Nasdaq
- JAZZ Nasdaq
- Market Cap
- CWST 6.3B
- JAZZ 6.5B
- IPO Year
- CWST 1997
- JAZZ 2007
- Fundamental
- Price
- CWST $108.32
- JAZZ $110.55
- Analyst Decision
- CWST Strong Buy
- JAZZ Buy
- Analyst Count
- CWST 5
- JAZZ 15
- Target Price
- CWST $103.80
- JAZZ $173.07
- AVG Volume (30 Days)
- CWST 187.0K
- JAZZ 758.2K
- Earning Date
- CWST 10-30-2024
- JAZZ 11-06-2024
- Dividend Yield
- CWST N/A
- JAZZ N/A
- EPS Growth
- CWST N/A
- JAZZ N/A
- EPS
- CWST 0.33
- JAZZ 5.93
- Revenue
- CWST $1,430,471,000.00
- JAZZ $3,909,883,000.00
- Revenue This Year
- CWST $23.76
- JAZZ $7.43
- Revenue Next Year
- CWST $8.88
- JAZZ $6.85
- P/E Ratio
- CWST $326.34
- JAZZ $18.35
- Revenue Growth
- CWST 27.76
- JAZZ 3.91
- 52 Week Low
- CWST $72.97
- JAZZ $99.06
- 52 Week High
- CWST $108.62
- JAZZ $137.39
- Technical
- Relative Strength Index (RSI)
- CWST 61.18
- JAZZ 49.27
- Support Level
- CWST $102.38
- JAZZ $104.42
- Resistance Level
- CWST $108.48
- JAZZ $109.97
- Average True Range (ATR)
- CWST 1.94
- JAZZ 2.32
- MACD
- CWST 0.13
- JAZZ -0.45
- Stochastic Oscillator
- CWST 98.36
- JAZZ 40.19
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.